HORIZON Trademark

Trademark Overview

On Friday, September 13, 2019, a trademark application was filed for HORIZON with the United States Patent and Trademark Office. The USPTO has given the HORIZON trademark a serial number of 88616006. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 31, 2022. This trademark is owned by OrbusNeich Medical, Inc.. The HORIZON trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, catheters for Percutaneous Transluminal Coronary Angioplasty (PTCA) for use in the treatment of and or resolution of vascular obstructions which restrict blood flow; angioplasty catheter coated with antiproliferative drug
horizon

General Information

Serial Number88616006
Word MarkHORIZON
Filing DateFriday, September 13, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 31, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2020

Trademark Statements

Goods and ServicesMedical devices, namely, catheters for Percutaneous Transluminal Coronary Angioplasty (PTCA) for use in the treatment of and or resolution of vascular obstructions which restrict blood flow; angioplasty catheter coated with antiproliferative drug

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, September 22, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameORBUSNEICH MEDICAL PTE. LTD.
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressSINGAPORE 338729
SG
Party NameOrbusNeich Medical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFt. Lauderdale, FL 33309
Party NameOrbusNeich Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFt. Lauderdale, FL 33309

Trademark Events

Event DateEvent Description
Monday, October 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 31, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2022SOU EXTENSION 4 GRANTED
Monday, March 21, 2022SOU EXTENSION 4 FILED
Monday, March 21, 2022TEAS EXTENSION RECEIVED
Wednesday, November 24, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 24, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 22, 2021SOU EXTENSION 3 GRANTED
Tuesday, June 22, 2021SOU EXTENSION 3 FILED
Tuesday, June 22, 2021TEAS EXTENSION RECEIVED
Saturday, February 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 25, 2021SOU EXTENSION 2 GRANTED
Thursday, February 25, 2021SOU EXTENSION 2 FILED
Thursday, February 25, 2021TEAS EXTENSION RECEIVED
Friday, September 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 2, 2020SOU EXTENSION 1 GRANTED
Wednesday, September 2, 2020SOU EXTENSION 1 FILED
Wednesday, September 2, 2020TEAS EXTENSION RECEIVED
Wednesday, July 22, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 24, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 14, 2019ASSIGNED TO EXAMINER
Sunday, September 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 17, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

horizon angioplasty restrict which obstructions blood flow drug antiproliferative coated catheter